Cover Image
Market Research Report

North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product, Disease, Application, and Country

Published by The Insight Partners Product code 819818
Published Content info 152 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product, Disease, Application, and Country
Published: February 27, 2019 Content info: 152 Pages
Description

The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-generation sequencing. Whereas, strict government guidelines and lack of knowledge and detailed examination is likely to have a negative impact on the growth of the market in the coming years.

Humans are never alone as they coexist with the diverse microbial species that live within and upon humans. From recent studies it has been very clear that this microbial community is essentially another organ of the body that plays a crucial role in human physiology and disease. Several basic and translational research efforts have been initiated to focus on deciphering mechanisms of microbiome function and how it benefits the human health. Many human medical conditions (like inflammatory bowel diseases and obesity) have been closely associated with or are thought to be influenced by (asthma and diabetes) the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health.

The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome.

Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient's intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.

US is anticipated to lead the adoptions of Human microbiome across the North American region through the forecast period. The application of the human microbiome are beneficial for various treatment areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune diseases and more. To be specific with the applications of the human microbiome, it plays important role in the developments in wide range of diseases and disorders which includes cardiovascular disease, cancer, autoimmune, neurological disorders and more. Therefore, various programs are being organized in the country to grow the awareness of probiotics and prebiotics in order to enhance the human microbiome.

For instance, in February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego, by Kisaco Research that focused on 5 microbiome niches such as the gut, lung, oral, skin and vaginal and provided latest insights on microbiome research, clinical trials and collaborative partnerships.

Thus, owing to the above mentioned factors the market for the human microbiome is likely to grow with a significant growth rate in the coming forecast years.

NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION:

By Product

  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements
  • NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION

By Disease

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Others
  • NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION

By Application

  • Therapeutics
  • Diagnostics

By Country

  • U.S.
  • Canada
  • Mexico

Companies Mentioned:

  • Enterome
  • MicroBiome Therapeutics, LLC
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX Ltd.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00003319

TABLE OF CONTENTS

PART 1. INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. NORTH AMERICA HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. NORTH AMERICA HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

  • 3.1 OVERVIEW
  • 3.2 MARKET SEGMENTATION
    • 3.2.1 North America Human Microbiome Market - By Product
    • 3.2.2 North America Human Microbiome Market - By Disease
    • 3.2.3 North America Human Microbiome Market - By Application
    • 3.2.4 North America Human Microbiome Market - By Country
  • 3.3 PEST ANALYSIS
    • 3.3.1 North America - PEST Analysis

PART 4. NORTH AMERICA HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

  • 4.1 KEY MARKET DRIVERS
    • 4.1.1 Growing Prevalence of Chronic Diseases
    • 4.1.2 Increasing Research and Development on Human Microbiome-Based Therapies
    • 4.1.3 Rapid adoption of Metagenomics and Next-Generation Sequencing techniques
  • 4.2 KEY MARKET RESTRAINTS
    • 4.2.1 Stringent Regulatory Framework
    • 4.2.2 Lack of Expertise In Human Microbiome
  • 4.3 KEY MARKET OPPORTUNITIES
    • 4.3.1 Developing Fecal Microbiota Transplantation (FMT) Therapies
  • 4.4 FUTURE TRENDS
    • 4.4.1 Growing Human Microbiome Research in Drug Discovery
  • 4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - NORTH AMERICA ANALYSIS

  • 5.1 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
  • 5.2 MARKET POSITIONING
  • 5.3 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

  • 5.4 EXPERT OPINIONS

PART 6. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
  • 6.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • 6.4 FOODS MARKET
    • 6.4.1 Overview
    • 6.4.2 North America Foods Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.5 MEDICAL FOOD MARKET
    • 6.5.1 Overview
    • 6.5.2 North America Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.6 PROBIOTICS MARKET
    • 6.6.1 Overview
    • 6.6.2 North America Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.7 PREBIOTICS MARKET
    • 6.7.1 Overview
    • 6.7.2 North America Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.8 DRUGS MARKET
    • 6.8.1 Overview
    • 6.8.2 North America Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.9 DIAGNOSTIC DEVICES MARKET
    • 6.9.1 Overview
    • 6.9.2 North America Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.10 SUPPLEMENTS MARKET
    • 6.10.1 Overview
    • 6.10.2 North America Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

  • 7.1 OVERVIEW
  • 7.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)
  • 7.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • 7.4 DIABETES MARKET
    • 7.4.1 Overview
    • 7.4.2 North America Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.5 CANCER MARKET
    • 7.5.1 Overview
    • 7.5.2 North America Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.6 AUTOIMMUNE DISORDERS MARKET
    • 7.6.1 Overview
    • 7.6.2 North America Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.7 OBESITY MARKET
    • 7.7.1 Overview
    • 7.7.2 North America Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.8 MENTAL DISORDERS MARKET
    • 7.8.1 Overview
    • 7.8.2 North America Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.9 OTHERS MARKET
    • 7.9.1 Overview
    • 7.9.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)
  • 8.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • 8.4 DIAGNOSTICS MARKET
    • 8.4.1 Overview
    • 8.4.2 North America Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 8.5 THERAPEUTICS MARKET
    • 8.5.1 Overview
    • 8.5.2 North America Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 9.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • 9.4 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • 9.5 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • 9.6 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 9.7 US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.7.1 US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.7.2 US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.7.3 US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.7.4 US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.8 CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.8.1 Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.8.2 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.8.3 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.8.4 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.9 MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.9.1 Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.9.2 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.9.3 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.9.4 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • 10.3 ORGANIC GROWTH STRATEGIES
    • 10.3.1 Overview
    • 10.3.2 Product Launch & Approvals
    • 10.3.3 Expansion
    • 10.3.4 Patent and license
  • 10.4 INORGANIC GROWTH STRATEGIES
    • 10.4.1 Overview
    • 10.4.2 Acquisitions
    • 10.4.3 Partnerships, Collaborations & Agreements
    • 10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

  • 11.1 ENTEROME
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 MICROBIOME THERAPEUTICS, LLC
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Information
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 REBIOTIX INC.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 YAKULT HONSHA CO., LTD.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 OSEL INC.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 Swot Analysis
    • 11.5.6 Key Developments
  • 11.6 VEDANTA BIOSCIENCES, INC.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Information
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 METABIOMICS CORPORATE
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 SYNTHETIC BIOLOGICS, INC.
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Information
    • 11.8.4 Product Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 DUPONT
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 BIOMX
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Information
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

PART 12. APPENDIX

  • 12.1 ABOUT THE INSIGHT PARTNERS
  • 12.2 GLOSSARY OF TERMS
  • 12.3 METHODOLOGY
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • TABLE 1. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 2. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 5. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 7. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 8. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 9. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 10. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 11. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 12. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 13. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 14. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 15. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET
  • TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
  • TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
  • TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

  • FIGURE 1. US HUMAN MICROBIOME MARKET, REVENUE (US$ MN), BY COUNTRIES 2018 & 2025
  • FIGURE 2. NORTH AMERICA HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017
  • FIGURE 3. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017
  • FIGURE 4. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017
  • FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION
  • FIGURE 6. HUMAN MICROBIOME SEGMENTATION, BY REGION
  • FIGURE 7. NORTH AMERICA PEST ANALYSIS
  • FIGURE 8. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
  • FIGURE 9. NORTH AMERICA HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
  • FIGURE 10. NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
  • FIGURE 11. NORTH AMERICA FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 12. NORTH AMERICA MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 13. NORTH AMERICA PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 14. NORTH AMERICA PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 15. NORTH AMERICA DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 16. NORTH AMERICA DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 17. NORTH AMERICA SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 18. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)
  • FIGURE 19. NORTH AMERICA DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 20. NORTH AMERICA CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 21. NORTH AMERICA AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 22. NORTH AMERICA OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 23. NORTH AMERICA MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 24. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 25. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)
  • FIGURE 26. NORTH AMERICA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 27. NORTH AMERICA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 28. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
  • FIGURE 29. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 30. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • FIGURE 31. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 32. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 33. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 34. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • FIGURE 35. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • FIGURE 36. INORGANIC GROWTH STRATEGIES IN THE ENDOSCOPY DEVICE MARKET, 2015-2018
Back to Top